Listen to HBW Insight podcasts for our perspectives on regulation, policy, quality, R&D and key commercial topics.
In this episode, HBW Insight talks to Haleon’s global head of regulatory intelligence and policy, Ian Urquhart, about the innovative and flexible approaches that regulators took to ensuring access to medicines during the coronavirus pandemic. Urquhart speaks about his work with the Global Self-Care Federation, where the regulatory affairs committee which he chairs has been looking into what happened during the pandemic and drawing lessons for the future. Strengthening supply chains, Rx-to-OTC switch and e-commerce are all on the agenda for the organization, which has published a series of papers in these areas to inform future self-care policy and regulation across the world.
In this episode, HBW Insight speaks to Elan Sudberg, CEO of Alkemist Labs and chair of the American Herbal Product Association’s Psychedelic Plants and Fungi committee. Sudberg talks about the founding of the committee and the regulatory hoops that companies will have to jump through to research and develop psychedelic supplements, as well as the benefits that psychedelic plants are thought to have on human health.
In this episode, HBW Insight talks to regulatory expert Mihai Inceu about the challenges of innovating in Europe’s thriving food supplements market. Senior regulatory affairs officer at consultancy firm JensonR+, Inceu highlights some of the issues companies face in putting new wellness products onto the European market, particularly if they want to make health claims for herbal ingredients, also known as botanicals. As well as giving good advice about how to avoid getting into trouble with regulators, Inceu also points to some of the latest trends in this dynamic consumer health space.
In this podcast special, HBW Insight senior editor David Ridley is interviewed by CPHI's Rebecca Lumley about the latest trends in the European dietary supplements space. They discuss which products surged in popularity during the pandemic, the rise of self-care and the current regulatory environment in Europe.
In this episode, HBW Insight speaks to Johnson & Johnson Self-Care R&D lead Adam Ricciardone about four macro trends the company is observing worldwide: total wellness, sustainability, demographic shifts and the “techceleration” of self-care. Ricciardone talks about J&J's latest self-care technologies and why non-western countries, particularly in Asia, are quicker to adopt new consumer healthcare trends.
A special podcast featuring editors Elizabeth Orr and Marion Webb from Medtech Insight, Brenda Sandburg from Pink Sheet and Malcolm Spicer from HBW Insight discussing the US Supreme Court’s historic overturning of Roe v. Wade and implications for FDA-regulated sectors, from the abortion pill and OTC daily and emergency contraceptives to intrauterine devices and period-tracking apps.
Over the Counter 29 June 2022: OTC Birth Control In The Wake Of The US Supreme Court Decision With Victoria Nichols
In this episode, HBW Insight speaks to Victoria Nichols, project director of Free the Pill, a campaign supporting increased OTC oral contraceptive access in the US. In the wake of the Supreme Court’s decision to overturn Roe v. Wade on 24 June, Nichols discusses the importance of advocating for OTC birth control, the limited availability of OTC oral contraceptives in the US, and the current legislation being introduced that would help ensure OTC birth control is covered by insurance.
In this episode, HBW Insight speaks to Annika Greve from Loop and Terracycle about the work that they do reducing waste across industries. Loop works with companies like Bausch+Lomb to create packaging that can be bought, used, and then dropped off in big box stores where consumers regularly shop. The discussion ranges from how greenwashing from companies can harm consumer trust in the industry, to how relatively recent habits of disposability will ultimately drive how companies switch to sustainable practices.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.